908 Devices Inc.
908 Devices Inc.
- Market cap
- $360.52M
Your view on MASS
Overview
What the company does, where it operates, and who runs it.
About 908 Devices Inc.
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Kevin J. Knopp
- Headquarters
- 645 Summer Street, Boston, MA, US
- Industry
- Medical - Specialties
- Sector
- Healthcare
- CEO
- Kevin J. Knopp
- Headquarters
- 645 Summer Street, Boston, MA, US
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for 908 Devices Inc.. Starting points for 908 Devices Inc.: EPS -$0.59, beta 0.63 — an Medical - Specialties name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for 908 Devices Inc.. Trailing twelve-month EPS for 908 Devices Inc. stands at -$0.59. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Buy
Targets, low to high
Analyst ratings
3 firms, last 12 months- Strong Buy0
- Buy3
- Hold0
- Sell0
- Strong Sell0
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.09 | −$0.13 | −$0.82 | −$0.50 |
| Lowest estimate | −$0.10 | −$0.21 | −$1.19 | −$0.78 |
| Highest estimate | −$0.09 | −$0.04 | −$0.13 | −$0.02 |
| Number of analysts | 3 | 2 | 3 | 3 |
| A year ago | −$0.05 | −$0.221 | −$0.941 | — |
| Growth vs a year ago | −84.0% | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $20.81M | $16.29M | $69.20M | $82.11M |
| Lowest estimate | $20.68M | $16.05M | $69.07M | $81.51M |
| Highest estimate | $20.98M | $16.53M | $69.37M | $82.51M |
| Number of analysts | 4 | 3 | 5 | 5 |
| A year ago | $17.38M | $13.38M | $56.20M | — |
| Growth vs a year ago | +19.8% | +21.7% | +23.1% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for 908 Devices Inc.. 908 Devices Inc. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AAgilent Technologies, Inc. | Healthcare | Medical - Diagnostics & Research | $48.0B | ||
| QGENQiagen N.V. | Healthcare | Medical - Diagnostics & Research | $10.2B | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| NSCIFNanalysis Scientific Corp. | Healthcare | OTC | $12.4M | ||
| NYXHNyxoah S.A. | Healthcare | NASDAQ | $82.0M | ||
| OIL.AXOptiscan Imaging Limited | Healthcare | ASX | — | ||
| OMDDOrmand Industries Inc | Healthcare | OTC | $310 | ||
| OMRXOrthometrix, Inc. | Healthcare | OTC | $4,699 | ||
| OMWSOmnia Wellness Inc. | Healthcare | OTC | $46,301 | ||
| PBIOPressure BioSciences, Inc. | Healthcare | OTC | $20,484 | ||
| PMSNFProteome Sciences plc | Healthcare | OTC | $11.8M | ||
| QDELQuidelOrtho Corporation | Healthcare | NASDAQ | $570.9M | ||
| SDCCQSmileDirectClub, Inc. | Healthcare | OTC | $13,395 | ||
| SIShoulder Innovations, Inc. | Healthcare | NYSE | $421.6M | ||
| SSMXFSysmex Corporation | Healthcare | OTC | $5.4B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| ARKGARK Genomic Revolution ETF | $2.2B in assets | 1.09% | |
| AVUVAvantis U.S. Small Cap Value ETF | $31.6B in assets | 0.04% | |
| IWMiShares Russell 2000 ETF | $76.6B in assets | 0.01% | |
| VTIVanguard Total Stock Market ETF | $689.2B in assets | 0.00% | |
| SGRWHarbor Active Small Cap Growth ETF (SGRW) | $28M in assets | 0.94% | |
| FITEState Street SPDR S&P Kensho Future Security ETF | $150M in assets | 0.58% | |
| IWCiShares Micro-Cap ETF | $1.2B in assets | 0.08% | |
| VTWVVanguard Russell 2000 Value ETF | $1.3B in assets | 0.02% | |
Largest holders first, then the funds most concentrated in MASS.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold 908 Devices Inc., and how their positions are changing. At a $360.5M market value, institutional positions materially move 908 Devices Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by 908 Devices Inc. executives and directors. Shares of 908 Devices Inc. have traded between $1.81 and $9.34 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for 908 Devices Inc.. Coverage tracks 908 Devices Inc. within Medical - Specialties (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of 908 Devices Inc.